Calidi Biotherapeutics (CLDI) Gains from Sales and Divestitures (2023 - 2025)
Calidi Biotherapeutics' quarterly Gains from Sales and Divestitures came in at $2000.0 in Q4 2025, down 94.74% year-on-year from $38000.0 in Q4 2024, and little changed quarter-over-quarter from $2000.0 in Q3 2025.
Calidi Biotherapeutics has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $2000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Sales and Divestitures fell 94.74% year-over-year to $2000.0; the trailing twelve-month figure through Dec 2025 stood at $2000.0 (down 94.74% YoY), and the FY2025 full-year result was $2000.0, down 94.74% from the prior year.
- Gains from Sales and Divestitures for Q4 2025 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $40000.0 in Q4 2023, with the low at $2000.0 in Q2 2025.
- Average Gains from Sales and Divestitures over 3 years is $18166.7, with a median of $13500.0 recorded in 2025.
- Year-over-year, Gains from Sales and Divestitures dropped 5.0% in 2024 and plunged 94.74% in 2025.
- Tracing CLDI's Gains from Sales and Divestitures over 3 years: stood at $40000.0 in 2023, then decreased by 5.0% to $38000.0 in 2024, then tumbled by 94.74% to $2000.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $2000.0 (Q4 2025), $2000.0 (Q3 2025), and $2000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Calidi Biotherapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2023 | 40,000.00 |